Different altered stage correlative expression of high abundance acute-phase proteins in sera of patients with epithelial ovarian carcinoma

Journal of Hematology and Oncology

Volumn 2, Issue , 2009, Pages

  Chen, Yeng ^a,b   Lim, Boon Kiong ^a   Hashim, Onn N ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b INSTITUTE FOR RESEARCH IN MOLECULAR MEDICINE INFORMM   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 1 ANTITRYPSIN; CLUSTERIN; HAPTOGLOBIN BETA; LEUCINE RICH GLYCOPROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; OVARY CARCINOMA; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TWO DIMENSIONAL GEL ELECTROPHORESIS; BLOOD; CARCINOMA IN SITU; CASE CONTROL STUDY; METABOLISM; METABOLOME; MIDDLE AGED; OSMOLARITY; OVARY TUMOR; PATHOLOGY; PROGNOSIS;

ACUTE-PHASE PROTEINS; ADULT; AGED; CARCINOMA IN SITU; CASE-CONTROL STUDIES; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; METABOLOME; MIDDLE AGED; NEOPLASM STAGING; OSMOLAR CONCENTRATION; OVARIAN NEOPLASMS; PROGNOSIS; YOUNG ADULT;

EID: 70349100798     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-2-37     Document Type: Article

References (32)

1. Tissue and serum CA125 expression in endometrial cancer. S Ginath J Menczer Y Fintsi E Ben-Shem M Glezerman I Avinoach, Int J Gynecol Cancer 2002 12 372 375 10.1046/j.1525-1438.2002.01007.x 12144685 (Pubitemid 34839835)
2. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. RC Bast Jr TL Klug E St John E Jenison JM Niloff H Lazarus RS Berkowitz T Leavitt CT Griffiths L Parker VR Zurawski Jr RC Knapp, N Engl J Med 1983 309 883 887 6310399
3. The CA125 tumor associated antigen: a review of the literature. IJ Jacobs RC Bast Jr, Hum Reprod 1989 4 1 12
4. Coxsackie and adenovirus receptor (CAR)-dependent and major MHC class 1-dependent uptake of recombinant adenoviruses into human tumour cells. D MacDonald L Stockwin T Matzow MB Zajdel G Blair, Gene Ther 1999 6 1512 1519 10.1038/sj.gt.3301006 10490760 (Pubitemid 29465509)
5. Clinical proteomics for cancer biomarker discovery and therapeutic targeting. RC Krieg CP Paweletz LA Liotta EF Petricoin III, Technol Cancer Res Treat 2002 1 263 272 12625785
6. Profiling of serum and tissue high abundance acute-phase proteins of patients with epithelial and germ line ovarian carcinoma. Y Chen BK Lim SC Peh PS Abdul-Rahman OH Hashim, Proteome Sci 2008 6 20 10.1186/1477-5956-6-20 18637207
7. Aberrant expression of acute-phase reactant proteins in sera and breast lesions from patients with malignant and benign breast tumours. SR Doustjalali R Yusof CH Yip LM Looi B Pillay OH Hashim, Electrophoresis 2004 25 2392 2401 10.1002/elps.200305950 15274022 (Pubitemid 39136360)
8. Patients with nasopharyngeal carcinoma demonstrate enhanced serum and tissue ceruloplasmin expression. SR Doustjalali R Yusof GK Govindasamy AZ Bustam B Pillay OH Hashim, J Med Invest 2006 53 20 28 10.2152/jmi.53.20 16537992
9. Expression of high abundance proteins in sera of patients with endometrial and cervical cancers: analysis using two-dimensional gel electrophoresis with silver staining and lectin detection methods. PS Abdul-Rahman BK Lim OH Hashim, Electrophoresis 2007 28 1989 1996 10.1002/elps.200600629 17503403 (Pubitemid 47040404)
10. Lectin-based electrophoretic analysis of the expression of the 35 kDa inter-alpha-trypsin inhibitor heavy chain H4 fragment in sera of patients with five different malignancies. E Mohamed PS Abdul-Rahman SR Doustjalali Y Chen BK Lim SZ Omar AZ Bustam VA Singh NA Muhammad-Taib CH Yip OH Hashim, Electrophoresis 2008 29 2645 2650 10.1002/elps.200700828 18494030 (Pubitemid 351911892)
11. Improved silver staining procedure for fast staining in PhastSystem development unit. I. Staining of sodium dodecyl sulphate gels. J Heukeshoven R Dernick, Electrophoresis 1988 9 28 32 10.1002/elps.1150090106 2466645
12. Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. A Shevchenko M Wilm O Vorm M Mann, Anal Chem 1996 68 850 858 10.1021/ac950914h 8779443 (Pubitemid 26101214)
13. Clusterin protects against oxidative stress in vitro through aggregative and nonaggregative properties. GB Schwochau KA Nath ME Rosenberg, Kidney Int 1998 53 1647 1653 10.1046/j.1523-1755.1998.00902.x 9607196 (Pubitemid 28243748)
14. Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer. H Miyake C Nelson PS Rennie ME Gleave, Cancer Res 2000 60 170 176 10646870 (Pubitemid 30058748)
15. Functional analysis of clusterin/apolipoprotein J in cellular death induced by severe genotoxic stress. IP Trougakos GS Gonos, Ann N Y Acad Sci 2004 1019 206 210 10.1196/annals.1297.033 15247015 (Pubitemid 38951306)
16. Cytoplasmic clusterin expression is associated with longer survival in patients with resected non small cell lung cancer. JM Albert A Gonzalez PP Massion H Chen SJ Olson Y Shyr R Diaz ES Lambright A Sandler DP Carbone JB Putnam Jr DH Johnson B Lu, Cancer Epidemiol Biomarkers Prev 2007 16 1845 1851 10.1158/1055-9965.EPI-07-0146 17855704 (Pubitemid 47450516)
17. Prognostic significance of clusterin immunoreactivity in breast cancer. S Krüger V Ola D Fischer AC Feller M Friedrich, Neoplasma 2007 54 46 50 17203891
18. Two-dimensional electrophoretic patterns of acute-phase human serum proteins in the course of bacterial and viral diseases. L Bini B Magi B Marzocchi C Cellesi B Berti R Raggiaschi A Rossolini V Pallini, Electrophoresis 1996 17 612 616 10.1002/elps.1150170333 8740187 (Pubitemid 26126807)
19. Plasma proteome of severe acute respiratory syndrome analyzed by two-dimensional electrophoresis and mass spectrometry. JH Chen YW Chang CW Yao TS Chiueh SC Huang KY Chien, Proc Natl Acad Sci USA 2004 101 17039 17044 10.1073/pnas.0407992101 15572443 (Pubitemid 39627770)
20. Proteomic analysis of sera from hepatocellular carcinoma patients after radiofrequency ablation treatment. T Kawakami Y Hoshida F Kanai Y Tanaka K Tateishi T Ikenoue S Obi S Sato T Teratani S Shiina T Kawabe T Suzuki N Hatano H Taniguchi M Omata, Proteomics 2005 5 4287 4295 10.1002/pmic.200401287 16254924 (Pubitemid 41626096)
21. Plasma proteomics of lung cancer by linkage of multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis. T Okano T Kondo T Kakisaka K Fujii M Yamada H Kato T Nishimura A Gemma S Kudoh S Hirohashi, Proteomics 2006 6 3938 3948 10.1002/pmic.200500883 16767791 (Pubitemid 44065171)
22. Plasma proteomics of pancreatic cancer patients by multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis (2D-DIGE): up-regulation of leucine-rich alpha-2-glycoprotein in pancreatic cancer. T Kakisaka T Kondo T Okano K Fujii K Honda M Endo A Tsuchida T Aoki T Itoi F Moriyasu M Yamada H Kato T Nishimura S Todo S Hirohashi, J Chromatogr B Biomed Sci Appl 2007 852 257 267 10.1016/j.jchromb.2007.01.029 (Pubitemid 46830120)
23. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS. SH Heo SJ Lee HM Ryoo JY Park JY Cho, Proteomics 2007 7 4292 4302 10.1002/pmic.200700433 17963278 (Pubitemid 350250474)
24. SERPINA3 (aka alpha-1-antichymotrypsin). C Baker O Belbin N Kalsheker K Morgan, Front Biosci 2007 12 2821 2835 10.2741/2275 17485262
25. Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins. JM Koomen LN Shih KR Coombes D Li LC Xiao IJ Fidler JL Abbruzzese R Kobayashi, Clin Cancer Res 2005 11 1110 1118 15709178
26. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry. KH Yu AK Rustgi IA Blair, J Proteome Res 2005 4 1742 1751 10.1021/pr050174l 16212428 (Pubitemid 41464802)
27. Biology of prostate-specific antigen. H Lilja, Urology 2003 62 27 33 10.1016/S0090-4295(03)00775-1 14607215 (Pubitemid 37371887)
28. Prostate-specific antigen expression by various tumors. C Kapadia GM Yousef AA Mellati A Magklara GA Wasney EP Diamandis, J Clin Lab Anal 1995 9 123 128 10.1002/jcla.1860090209 7536238
29. Circulating haptoglobin is an independent prognostic factor in the sera of patients with epithelial ovarian cancer. C Zhao L Annamalai C Guo N Kothandaraman SC Koh H Zhang A Biswas M Choolani, Neoplasia 2007 9 1 7 10.1593/neo.06619 17325738 (Pubitemid 46203929)
30. Increased plasma levels of serine proteinase inhibitors in lung cancer patients. I Zelvyte A Wallmark E Piitulainen U Westin S Janciauskiene, Anticancer Res 2004 24 241 247 15015603
31. Activity of cathepsin D and alpha(1)-antitrypsin in the blood serum of patients with mammary carcinoma. A Wozniak C Mila-Kierzenkowska DO Schachtschabel B Wozniak M Rozwodowska T Drewa S Drewa J Sir I Sir R Maciak E Krzyzynska-Malinowska, Exp Oncol 2005 27 233 237 16244588
32. The effect of combined therapy on activity of cathepsin D and alpha-1-antitrypsin in the blood serum of women with cervical cancer. B Woniak C Mila-Kierzenkowska A Woniak G Drewa M Sopõska T Drewa E Krzyzỹska-Malinowska R Makarewicz T Kowalski K Szmytkowska, Eur J Gynaecol Oncol 2008 29 617 619 19115690